Trichoplusia ni cells (High Five™) are highly efficient for the production of influenza A virus-like particles: A comparison of two insect cell lines as production platforms for influenza vaccines

Molecular Biotechnology

Volumn 45, Issue 3, 2010, Pages 226-234

  Krammer, Florian ^a   Schinko, Theresa ^a   Palmberger, Dieter ^a   Tauer, Christopher ^a   Messner, Paul ^a   Grabherr, Reingard ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Baculovirus; Influenza; Influenza vaccine; Insect cells; Virus like particles

Indexed keywords

ALTERNATIVE APPROACH; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEMS; CELL LINES; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA VIRUS; INSECT CELL LINES; INSECT CELLS; MATRIX PROTEINS; PARTICLE DENSITIES; PRODUCTION CELLS; SPODOPTERA FRUGIPERDA; TRICHOPLUSIA NI; VIRUS-LIKE PARTICLES;

CELL CULTURE; DRILLING PLATFORMS; PRODUCTION PLATFORMS; PROTEINS; STRAIN; VACCINES; VIRUSES;

CELLS;

ANAZOLENE SODIUM; HEMAGGLUTININ; INFLUENZA VACCINE; MATRIX PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARMYWORM; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; INFLUENZA VIRUS A; INSECT CELL; NONHUMAN; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; TRICHOPLUSIA NI CELLS; VIRUS LIKE AGENT; VIRUS STRAIN; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; BLOTTING, WESTERN; CELL LINE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; SPODOPTERA; VIRAL MATRIX PROTEINS; VIRION;

HEXAPODA; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SPODOPTERA FRUGIPERDA; SUIDAE; TRICHOPLUSIA NI;

EID: 77954951040     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-010-9268-3     Document Type: Article

References (35)

1. Michaelis, M., Doerr, H., & Cinatl, J. J. (2009). Novel swineorigin influenza A virus in humans: another pandemic knocking at the door. Medical Microbiology and Immunology, 198(3), 175-183.
2. Nicholson, K., Wood, J., & Zambon, M. (2003). Influenza. Lancet, 362, 1733-1745.
3. Erlewyn-Lajeunesse, M., Brathwaite, N., Lucas, J., & Warner, J. (2009). Recommendations for the administration of influenza vaccine in children allergic to egg. BMJ, 339, b3680.
4. Biesova, Z., Miller, M., Schneerson, R., Shiloach, J., Green, K., Robbins, J., et al. (2009). Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus. Vaccine, 27, 6234-6238.
5. Cox, M. (2008). Progress on baculovirus-derived influenza vaccines. Current Opinion in Molecular Therapeutics, 10, 56-61.
6. D'Aoust, M., Lavoie, P., Couture, M., Trépanier, S., Guay, J., Dargis, M., et al. (2008). Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnology Journal, 6, 930-940.
7. Zheng, L., Wang, F., Yang, Z., Chen, J., Chang, H., & Chen, Z. (2009). A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice. BMC Infectious Diseases, 9, 17.
8. Szécsi, J., Boson, B., Johnsson, P., Dupeyrot-Lacas, P., Matrosovich, M., Klenk, H., et al. (2006). Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses. Virology Journal, 3, 70.
9. Nayak, D., Balogun, R., Yamada, H., Zhou, Z., & Barman, S. (2009). Influenza virus morphogenesis and budding. Virus Research, 143(2), 147-161.
10. Roy, P., & Noad, R. (2008). Virus-like particles as a vaccine delivery system: myths and facts. Human Vaccines 4, 5-12.
11. Kang, S., Song, J., Quan, F., & Compans, R. (2009). Influenza vaccines based on virus-like particles. Virus Research, 143, 140-146.
12. Schiller, J., Castellsagué, X., Villa, L., & Hildesheim, A. (2008). An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine, 26(Suppl 10), K53-K61.
13. Bright, R., Carter, D., Daniluk, S., Toapanta, F., Ahmad, A., Gavrilov, V., et al. (2007). Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine, 25, 3871-3878.
14. Mahmood, K., Bright, R., Mytle, N., Carter, D., Crevar, C., Achenbach, J., et al. (2008). H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine, 26, 5393-5399.
15. Ross, T., Mahmood, K., Crevar, C., Schneider-Ohrum, K., Heaton, P., & Bright, R. (2009). A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS One, 4, e6032.
16. Perrone, L., Ahmad, A., Veguilla, V., Lu, X., Smith, G., Katz, J., et al. (2009). Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. Journal of Virology, 83, 5726-5734.
17. Quan, F., Huang, C., Compans, R., & Kang, S. (2007). Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. Journal of Virology, 81, 3514-3524.
18. Galarza, J., Latham, T., & Cupo, A. (2005). Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunology, 18, 244-251. (Pubitemid 40586463)
19. Latham, T., & Galarza, J. (2001). Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Journal of Virology, 75, 6154-6165.
20. Pushko, P., Tumpey, T., Bu, F., Knell, J., Robinson, R., & Smith, G. (2005). Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine, 23, 5751-5759.
21. Wickham, T., Davis, T., Granados, R., Shuler, M., & Wood, H. (1992). Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system. Biotechnology Progress, 8, 391-396.
22. King, L., Hitchman, R., & Possee, R. (2007). Recombinant baculovirus isolation. Methods in Molecular Biology, 388, 77-94.
23. Laemmli, U. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
24. Mäkelä, A., Tuusa, J., Volkman, L., & Oker-Blom, C. (2008). Occlusion-derived baculovirus: interaction with human cells and evaluation of the envelope protein P74 as a surface display platform. Journal of Biotechnology, 135, 145-156.
25. Sarkar, N., Manthey, W., & Sheffield, J. (1975). The morphology of murine oncornaviruses following different methods of preparation for electron microscopy. Cancer Research, 35, 740-749.
26. Harris, A., Cardone, G., Winkler, D., Heymann, J., Brecher, M., White, J., et al. (2006). Influenza virus pleiomorphy characterized by cryoelectron tomography. Proceedings of the National Academy of Sciences of the United States of America, 103, 19123-19127.
27. Krammer, F., Nakowitsch, S., Messner, P., Palmberger, D., Ferko, B., & Grabherr, R. (2010). Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice. Biotechnology Journal, 5, 17-23.
28. Hu, Y. (2008). Baculoviral vectors for gene delivery: a review. Current Gene Therapy, 8, 54-65.
29. Kost, T., & Condreay, J. (1999). Recombinant baculoviruses as expression vectors for insect and mammalian cells. Current Opinion in Biotechnology, 10, 428-433.
30. Kost, T., & Condreay, J. (2002). Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends in Biotechnology, 20, 173-180.
31. Nakowitsch, S., Kittel, C., Ernst, W., Egorov, A., & Grabherr, R. (2006). Optimization of baculovirus transduction on Free- Style293 cells for the generation of influenza B/Lee/40. Molecular Biotechnology, 34, 157-164.
32. Ernst, W., Schinko, T., Spenger, A., Oker-Blom, C., & Grabherr, R. (2006). Improving baculovirus transduction of mammalian cells by surface display of a RGD-motif. Journal of Biotechnology, 126, 237-240. (Pubitemid 44528773)
33. Spenger, A., Ernst, W., Condreay, J., Kost, T., & Grabherr, R. (2004). Influence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells. Protein Expression and Purification, 38, 17-23.
34. Abe, T., Takahashi, H., Hamazaki, H., Miyano-Kurosaki, N., Matsuura, Y., & Takaku, H. (2003). Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. Journal of Immunology, 171, 1133-1139.
35. Abe, T., Hemmi, H., Miyamoto, H., Moriishi, K., Tamura, S., Takaku, H., et al. (2005). Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. Journal of Virology, 79, 2847-2858.